Latest News by Industry
SAN CARLOS, Calif. (AP) — SAN CARLOS, Calif. (AP) — Iovance Biotherapeutics Inc. (IOVA) on Thursday reported a loss of $83.5 million in its third quarter.
On a per-share basis, the San Carlos, California-based company said it had a loss of 28 cents.
The results surpassed Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was for a loss of 31 cents per share.
The biotechnology company posted revenue of $58.6 million in the period, also topping Street forecasts. Six analysts surveyed by Zacks expected $53.5 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on IOVA at https://www.zacks.com/ap/IOVA